Role of GPR110 on tumorigenesis and metastasis in HER2+breast cancer in the context of anti-HER2 drug resistance

被引：0
|
作者：
Sahay, Debashish
Bhat, Raksha
Rimawi, Motthafar
Osborne, C. Kent
Schiff, Rachel
Trivedi, Meghana V.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-319
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
319
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer
    Adela Madrid-Paredes
    Marisa Cañadas-Garre
    Antonio Sánchez-Pozo
    Miguel Ángel Calleja-Hernández
    Breast Cancer Research and Treatment, 2015, 153 : 493 - 505
  • [22] The perspective of anti-HER2 therapy for HER2 positive breast cancer
    Iwata, Hiroji
    ANNALS OF ONCOLOGY, 2015, 26 : 11 - 11
  • [23] Insights into the molecular underpinnings of the mevalonate pathway-YAP/TAZ-driven anti-HER2 therapy resistance in HER2+breast cancer (BC)
    Sethunath, Vidyalakshmi
    Fu, Xiaoyong
    Luna, Pamela L.
    Nanda, Sarmistha
    Shea, Martin
    Veeraraghavan, Jamunarani
    De Angelis, Carmine
    Hu, Huizhong
    Shaw, Chad
    Rimawi, Mothaffar
    Osborne, C. Kent
    Schiff, Rachel
    CANCER RESEARCH, 2021, 81 (04)
  • [24] HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
    Alberto Ocaña
    Eitan Amir
    Atanasio Pandiella
    Breast Cancer Research, 22
  • [25] IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+breast cancer
    Ong, Li-Teng
    Lee, Wee Chyan
    Ma, Shijun
    Oguz, Gokce
    Niu, Zhitong
    Bao, Yi
    Yusuf, Mubaraka
    Lee, Puay Leng
    Goh, Jian Yuan
    Wang, Panpan
    Yong, Kylie Su Mei
    Chen, Qingfeng
    Wang, Wenyu
    Ramasamy, Adaikalavan
    Hoon, Dave S. B.
    Ditzel, Henrik J.
    Tan, Ern Yu
    Lee, Soo Chin
    Yu, Qiang
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (31)
  • [26] HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
    Ocana, Alberto
    Amir, Eitan
    Pandiella, Atanasio
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [27] The role of SHP2 in HER2+breast cancer
    Wang, Xiaonan
    CANCER RESEARCH, 2012, 72
  • [28] Anti-HER2 induced myeloid cell alterations correspond with increasing vascular maturation in a murine model of HER2+breast cancer
    Bloom, Meghan J.
    Jarrett, Angela M.
    Triplett, Todd A.
    Syed, Anum K.
    Davis, Tessa
    Yankeelov, Thomas E.
    Sorace, Anna G.
    BMC CANCER, 2020, 20 (01)
  • [29] RESISTANCE TO ANTI-HER2 AGENTS
    Mukohara, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 78 - 78
  • [30] RESISTANCE TO ANTI-HER2 THERAPIES
    Sledge, George W.
    BREAST, 2011, 20 : S16 - S16
12345